Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.2%

85 terminated/withdrawn out of 2039 trials

Success Rate

92.7%

+6.2% vs industry average

Late-Stage Pipeline

15%

306 trials in Phase 3/4

Results Transparency

8%

81 of 1073 completed trials have results

Key Signals

178 recruiting81 with results55 terminated30 withdrawn

Enrollment Performance

Analytics

N/A
901(58.7%)
Phase 4
222(14.5%)
Phase 2
208(13.5%)
Phase 1
109(7.1%)
Phase 3
84(5.5%)
Early Phase 1
12(0.8%)
1536Total
N/A(901)
Phase 4(222)
Phase 2(208)
Phase 1(109)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2039)

Showing 20 of 2039 trials
NCT07577518Not ApplicableNot Yet Recruiting

Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome

Role: lead

NCT03535623Not ApplicableCompleted

RIPC During Free Flap With Preoperative Radiotherapy

Role: lead

NCT07641283Not ApplicableNot Yet Recruiting

Naltrexone for Nonsuicidal Self-Injury

Role: lead

NCT07638241Not ApplicableNot Yet Recruiting

Agentic AI Personalized Dietary Management Study

Role: lead

NCT07636044Recruiting

Reduced Vaccine Response to HZ/su in SLE

Role: lead

NCT07634523Phase 4Recruiting

Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty

Role: lead

NCT07615231Not ApplicableNot Yet Recruiting

EOI Block vs. TAP Block in Minimally Invasive Hepatectomy

Role: lead

NCT06159985Not ApplicableCompleted

Effect of Left Posterior Pericardiotomy for the Prevention of POAF

Role: lead

NCT07621458Recruiting

Study on Cutoff Revision Effects and Evaluation of NNT in Primary Aldosteronism

Role: lead

NCT05993390Not ApplicableRecruiting

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

Role: lead

NCT05950958Not ApplicableRecruiting

Prevention of Delirium in ICU Using Multimodal Interventions

Role: lead

NCT07383870Not ApplicableCompleted

Clinical Evaluation of an AI- and Ultrasound-Assisted Venipuncture Device

Role: lead

NCT05846893Not ApplicableActive Not Recruiting

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease

Role: collaborator

NCT05138263Active Not Recruiting

Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)

Role: lead

NCT07609186Not ApplicableRecruiting

Binaural Sound During Phacoemulsification and Posterior Chamber Lens Implantation in Geriatric Patients

Role: lead

NCT06437054Phase 1Withdrawn

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

Role: lead

NCT06622239Phase 2Not Yet Recruiting

Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury

Role: lead

NCT07374679Recruiting

Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease

Role: lead

NCT05996159Not ApplicableRecruiting

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

Role: lead

NCT06148571Recruiting

Left Bundle Branch Area Pacing in Heart Failure Patients With Ejection Fraction Below Normal

Role: lead